Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2005 Filed Feb 23, 2005 22:49 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
GrantCommon shares without par value | 46,400 | $46.34 | $2,150,176.00 |
DisclosureSEC source: 0001104659-05-008009 · a4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,292 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:49 UTC |
ASHLEY RICHARD WExecutive Vice President
|
GrantCommon shares without par value | 30,500 | $46.34 | $1,413,370.00 |
DisclosureSEC source: 0001104659-05-008011 · a4.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,500 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:49 UTC |
DE LASA JOSE MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 91,600 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008012 · a4.xml · derivative · entry 1 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,600 Underlying: common shares · 91,600 shares Expires 2015-02-17 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Plan in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 30,534 on 02/18/06, 30,533 on 02/18/07, and 30,533 on 02/18/08. F1 · kind: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Plan in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 30,534 on 02/18/06, 30,533 on 02/18/07, and 30,533 on 02/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:50 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 63,800 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008013 · a4.xml · derivative · entry 3 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,800 Underlying: common shares · 63,800 shares Expires 2015-02-17 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 21,267 on 2/18/06, 21,267 on 2/18/07 and 21,266 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:50 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantCommon shares without par value | 9,300 | $46.34 | $430,962.00 |
DisclosureSEC source: 0001104659-05-008013 · a4.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,120 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:50 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
GrantOption (right to buy) · Derivative | 63,800 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008014 · a4.xml · derivative · entry 3 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,800 Underlying: common shares · 63,800 shares Expires 2015-02-17 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 21,267 on 2/18/06, 21,267 on 2/18/07, and 21,266 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:50 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
GrantCommon shares without par value | 9,300 | $46.34 | $430,962.00 |
DisclosureSEC source: 0001104659-05-008014 · a4.xml · nonDerivative · entry 1 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,909 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:50 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 63,800 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008015 · a4.xml · derivative · entry 5 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,800 Underlying: common shares · 63,800 shares Expires 2015-02-17 F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 21,267 on 2/18/06, 21,267 on 2/18/07 and 21,266 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:50 UTC |
Landgraf John CSenior Vice President
|
GrantCommon shares without par value | 9,300 | $46.34 | $430,962.00 |
DisclosureSEC source: 0001104659-05-008015 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,368 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:51 UTC |
LIEPMANN HOLGER ASenior Vice President
|
GrantOption (right to buy) · Derivative | 63,800 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008016 · a4.xml · derivative · entry 5 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,800 Underlying: Common shares · 63,800 shares Expires 2015-02-17 F4 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 21,267 on 2/18/06, 21,267 on 2/18/07 and 21,266 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:51 UTC |
LIEPMANN HOLGER ASenior Vice President
|
GrantCommon shares without par value | 9,300 | $46.34 | $430,962.00 |
DisclosureSEC source: 0001104659-05-008016 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,885 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:51 UTC |
MCCULLOUGH GARY ESenior Vice President
|
GrantOption (right to buy) · Derivative | 63,800 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008017 · a4.xml · derivative · entry 2 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,800 Underlying: common shares · 63,800 shares Expires 2015-02-17 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 21,267 on 2/18/06, 21,267 on 2/18/07 and 21,266 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:51 UTC |
MCCULLOUGH GARY ESenior Vice President
|
GrantCommon shares without par value | 9,300 | $46.34 | $430,962.00 |
DisclosureSEC source: 0001104659-05-008017 · a4.xml · nonDerivative · entry 1 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,329 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:51 UTC |
WASCOE THOMAS MSenior Vice President
|
GrantOption (right to buy) · Derivative | 91,600 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008019 · a4.xml · derivative · entry 1 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,600 Underlying: common shares · 91,600 shares Expires 2015-02-17 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 30,534 on 2/18/06, 30,533 on 2/18/07 and 30,533 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:51 UTC |
NEMMERS JOSEPH MSenior Vice President
|
GrantOption (right to buy) · Derivative | 63,800 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008018 · a4.xml · derivative · entry 7 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,800 Underlying: common shares · 63,800 shares Expires 2015-02-17 F5 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 21,267 on 2/18/06, 21,267 on 2/18/07, and 21,266 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:51 UTC |
NEMMERS JOSEPH MSenior Vice President
|
GrantCommon shares without par value | 9,300 | $46.34 | $430,962.00 |
DisclosureSEC source: 0001104659-05-008018 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,530 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:52 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 34,800 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008020 · a4.xml · derivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,800 Underlying: common shares · 34,800 shares Expires 2015-02-17 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 11,600 on 2/18/06, 11,600 on 2/18/07 and 11,600 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:52 UTC |
LINDER GREG WVice President
|
GrantCommon shares without par value | 5,200 | $46.34 | $240,968.00 |
DisclosureSEC source: 0001104659-05-008020 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,143 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 14, 2005 Filed Feb 16, 2005 00:54 UTC |
DE LASA JOSE MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 26,531 | $0.00 Strike: $46.20 | $0.00 |
DisclosureSEC source: 0001104659-05-006833 · a4.xml · derivative · entry 5 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,531 Underlying: common shares · 26,531 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 14, 2005 Filed Feb 16, 2005 00:54 UTC |
DE LASA JOSE MExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 31,922 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-05-006833 · a4.xml · derivative · entry 4 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,922 Underlying: common shares · 31,922 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 14, 2005 Filed Feb 16, 2005 00:54 UTC |
DE LASA JOSE MExecutive Vice President
|
Tax withholdingCommon shares without par value | 26,531 | $46.20 | $1,225,732.20 |
DisclosureSEC source: 0001104659-05-006833 · a4.xml · nonDerivative · entry 2 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,001 Read SEC document |
| February 14, 2005 Filed Feb 16, 2005 00:54 UTC |
DE LASA JOSE MExecutive Vice President
|
Exercise / conversionCommon shares without par value | 31,922 | $33.23 | $1,060,812.75 |
DisclosureSEC source: 0001104659-05-006833 · a4.xml · nonDerivative · entry 1 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2005 Filed Feb 14, 2005 21:08 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Tax withholdingCommon shares without par value | 4,197 | $45.77 | $192,096.69 |
DisclosureSEC source: 0001104659-05-006391 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,000 Read SEC document |
| February 02, 2005 Filed Feb 4, 2005 19:01 UTC |
DE LASA JOSE MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 2,194 | $0.00 Strike: $45.55 | $0.00 |
DisclosureSEC source: 0001104659-05-004072 · a4.xml · derivative · entry 5 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,194 Underlying: common shares · 2,194 shares Expires 2008-02-12 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 02, 2005 Filed Feb 4, 2005 19:01 UTC |
DE LASA JOSE MExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,875 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-05-004072 · a4.xml · derivative · entry 4 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,875 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 02, 2005 Filed Feb 4, 2005 19:01 UTC |
DE LASA JOSE MExecutive Vice President
|
Tax withholdingCommon shares without par value | 2,194 | $45.55 | $99,936.70 |
DisclosureSEC source: 0001104659-05-004072 · a4.xml · nonDerivative · entry 2 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,610 Read SEC document |
| February 02, 2005 Filed Feb 4, 2005 19:01 UTC |
DE LASA JOSE MExecutive Vice President
|
Exercise / conversionCommon shares without par value | 2,875 | $34.77 | $99,971.51 |
DisclosureSEC source: 0001104659-05-004072 · a4.xml · nonDerivative · entry 1 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2005 Filed Jan 25, 2005 18:31 UTC |
NEMMERS JOSEPH MSenior Vice President
|
SaleCommon shares without par value | 8,728 | $45.85 | $400,157.85 |
DisclosureSEC source: 0001104659-05-002467 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,230 Read SEC document |
| January 21, 2005 Filed Jan 26, 2005 00:33 UTC |
Landgraf John CSenior Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 9,221 | $0.00 Strike: $18.39 | $0.00 |
DisclosureSEC source: 0001104659-05-002542 · a4.xml · derivative · entry 9 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 9,221 shares Expires 2005-04-27 Read SEC document |
| January 21, 2005 Filed Jan 26, 2005 00:33 UTC |
Landgraf John CSenior Vice President
|
GiftCommon Shares without par value | 5,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-002542 · a4.xml · nonDerivative · entry 6 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Anne Marie Landgraf Living Trust Disclosed balance after: 38,550 F1 · balance_after: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse. 27,477 of the shares held by the trust were previously incorrectly reported as being directly owned by the reporting person. Read SEC document |
| January 21, 2005 Filed Jan 26, 2005 00:33 UTC |
Landgraf John CSenior Vice President
|
GiftCommon Shares without par value | 5,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-002542 · a4.xml · nonDerivative · entry 4 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,068 Read SEC document |
| January 21, 2005 Filed Jan 26, 2005 00:33 UTC |
Landgraf John CSenior Vice President
|
Tax withholdingCommon Shares without par value | 3,706 | $45.75 | $169,549.50 |
DisclosureSEC source: 0001104659-05-002542 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,583 Read SEC document |
| January 21, 2005 Filed Jan 26, 2005 00:33 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon Shares without par value | 9,221 | $18.39 | $169,591.71 |
DisclosureSEC source: 0001104659-05-002542 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2005 Filed Jan 4, 2005 19:29 UTC |
MCCULLOUGH GARY ESenior Vice President
|
Tax withholdingCommon shares without par value | 9,971 | $46.60 | $464,648.60 |
DisclosureSEC source: 0001104659-05-000221 · a4.xml · nonDerivative · entry 1 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,029 Read SEC document |
| December 31, 2004 Filed Jan 4, 2005 19:29 UTC |
DALEY WILLIAM MDirector
|
GrantStock equivalent units · Derivative | 285 | $46.65 Strike: $0.00 | $13,295.25 |
DisclosureSEC source: 0001104659-05-000220 · a4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285 Underlying: common shares · 285 shares Expires not disclosed F1 · derivative.exercise_price: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · kind: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. Read SEC document |
| December 31, 2004 Filed Jan 4, 2005 19:32 UTC |
SMITHBURG WILLIAM DDirector
|
GrantStock equivalent units · Derivative | 493 | $46.65 Strike: $0.00 | $22,998.45 |
DisclosureSEC source: 0001104659-05-000223 · a4.xml · derivative · entry 1 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,157 Underlying: common shares · 493 shares Expires not disclosed F1 · derivative.exercise_price: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · kind: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2004 Filed Jan 4, 2005 19:30 UTC |
POWELL BOONE JRDirector
|
GrantStock equivalent units · Derivative | 267 | $46.65 Strike: $0.00 | $12,455.55 |
DisclosureSEC source: 0001104659-05-000222 · a4.xml · derivative · entry 4 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,954 Underlying: common shares · 267 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 27, 2004 Filed Dec 28, 2004 22:37 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,000 | $0.00 Strike: $44.72 | $0.00 |
DisclosureSEC source: 0001104659-04-041408 · a4.xml · derivative · entry 4 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,000 shares Expires 2004-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 27, 2004 Filed Dec 28, 2004 22:37 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Tax withholdingCommon shares without par value | 1,955 | $46.42 | $90,751.10 |
DisclosureSEC source: 0001104659-04-041408 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,585 Read SEC document |
| December 27, 2004 Filed Dec 28, 2004 22:37 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Exercise / conversionCommon shares without par value | 2,000 | $44.72 | $89,431.40 |
DisclosureSEC source: 0001104659-04-041408 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2004 Filed Feb 1, 2005 17:21 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GiftCommon shares without par value | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-003427 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,197 Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 14,699 | $0.00 Strike: $46.42 | $0.00 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · derivative · entry 12 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,699 Underlying: common shares · 14,699 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 11,357 | $0.00 Strike: $46.42 | $0.00 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · derivative · entry 11 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,357 Underlying: common shares · 11,357 shares Expires 2010-02-10 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC |
Landgraf John CSenior Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 3,074 | $0.00 Strike: $45.47 | $0.00 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · derivative · entry 10 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,074 shares Expires 2005-04-27 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC |
Landgraf John CSenior Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 17,754 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · derivative · entry 9 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,088 Underlying: common shares · 17,754 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC |
Landgraf John CSenior Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 13,852 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · derivative · entry 8 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,065 Underlying: common shares · 13,852 shares Expires 2010-02-10 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC |
Landgraf John CSenior Vice President
|
Tax withholdingCommon shares without par value | 29,092 | $46.42 | $1,350,450.64 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · nonDerivative · entry 5 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,103 Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 3,074 | $45.47 | $139,781.85 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · nonDerivative · entry 4 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 17,754 | $33.23 | $589,990.28 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 13,852 | $32.61 | $451,728.96 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.